Launch week offerEnds in00h00m00s

annual Promonthly Pro

Katharina Rox

Helmholtz Centre for Infection Research

Germany

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Germany Professors in Microbiology Microbiology professors in Germany

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (16)

Daniel Hurdiss

Utrecht University

NETHERLANDS

View details

Nadine Krüger

Head of Unit

German Primate Center

GERMANY

View details

Dagmar Wirth

Head of Research Group

Helmholtz Centre for Infection Research

GERMANY

View details

Joe Joiner

University of Cambridge

UNITED KINGDOM

View details

Chunfa Xu

Senior scientist

Helmholtz Centre for Infection Research

GERMANY

View details

Raquel Mejías-Luque

Ludwig-Maximilians-Universität München

GERMANY

View details

Anna Katharina Herta Hirsch

Full professor (W3)

Saarland University

GERMANY

View details

Walid A. M Elgaher

Habilitand

Saarland University

GERMANY

View details

Mark Brönstrup

Department Head

Helmholtz-Zentrum für Infektionsforschung GmbH

GERMANY

View details

Antje Flieger

Professor of Microbiology

Robert Koch Institute

GERMANY

View details

Biao Yuan

Helmholtz Centre for Infection Research

GERMANY

View details

Brigitta Loretz

Senior Scientist

Helmholtz Institute for Pharmaceutical Research Saarland

GERMANY

View details

Richard Brown

Research Scientist

Ruhr-Universität Bochum

GERMANY

View details

Jennifer Herrmann

Helmholtz Institute for Pharmaceutical Research Saarland

GERMANY

View details

Antti Poso

Professor at University of Eastern Finland

University of Eastern Finland

FINLAND

View details

Carina Vingsbo Lundberg

Head of Antimicrobial resistance and pre-clinical research

Statens Serum Institut

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Katharina Rox

Research Interests

Make your next move.

Explore related searches

Articles (20)

Structure-based macrocyclization of α-ketoamides leads to potent inhibitors of coronaviral and enteroviral proteases

Metronidazole and ether derivatives target <i>Helicobacter pylori</i> via simultaneous stress induction and inhibition

A Streamlined High Performance Liquid Chromatography with Tandem Mass Spectrometry Based Workflow for Rapid Screening of Cellular Accumulation of Small Molecules

Exploiting Pharmacokinetic/Pharmacodynamic Methods for Optimizing and Accelerating Drug Development of Innovative Anti‐Infectives

Discovery of synthetic small molecules targeting the central regulator of Salmonella pathogenicity

Adapted hepatitis C virus clone infects innate immunity-deficient mouse hepatocytes with minimal human HCV entry factors

Correction to “Effective, but Safe? Physiologically Based Pharmacokinetic (PBPK)-Modeling-Based Dosing Study of Molnupiravir for Risk Assessment in Pediatric Subpopulations”

Development of Fragment-Based Inhibitors of the Bacterial Deacetylase LpxC with Low Nanomolar Activity

Interaction of the Atypical Tetracyclines Chelocardin and Amidochelocardin with Renal Drug Transporters

Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity

Pharmacokinetic and pharmacodynamic evaluation of the atypical tetracyclines chelocardin and amidochelocardin in murine infection models

Die Click‐to‐Release‐Aktivierung des Reserveantibiotikums Colistin am Zielort verringert dessen Nierentoxizität

Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor.

Effective, but Safe? Physiologically Based Pharmacokinetic (PBPK)-Modeling-Based Dosing Study of Molnupiravir for Risk Assessment in Pediatric Subpopulations

Optimization of the Central α-Amino Acid in Cystobactamids to the Broad-Spectrum, Resistance-Breaking Antibiotic CN-CC-861

Targeting Plasmodium falciparum IspD in the Methyl-d-erythritol Phosphate Pathway: Urea-Based Compounds with Nanomolar Potency on Target and Low-Micromolar Whole-Cell Activity

Glycomimetics as Candidates for Treatment and Prevention of Catheter-associated Biofilms Formed by Pseudomonas aeruginosa

Aerosolized delivery of ESKAPE pathogens for murine pneumonia models

Discovery of highly neutralizing human antibodies targeting Pseudomonas aeruginosa

Inhibitors of the Elastase LasB for the Treatment of <i>Pseudomonas aeruginosa</i> Lung Infections

Collaborators (16)

Daniel Hurdiss

Nadine Krüger

Dagmar Wirth

Joe Joiner

Chunfa Xu

Raquel Mejías-Luque

Anna Katharina Herta Hirsch

Walid A. M Elgaher

Mark Brönstrup

Antje Flieger

Biao Yuan

Brigitta Loretz

Richard Brown

Jennifer Herrmann

Antti Poso

Carina Vingsbo Lundberg

Make your next move.